Running:
Make sure you have a good pair of running shoes. If you find yourself losing breath, slow your pace down until you’ve recovered. If you are a novice runner try running and walking, until you can hold your run for 15 minutes. When your run is complete stretch your legs for 30 seconds per muscle, hamstring, calf and thigh.

Exercise bikes can be used in a variety of ways, general riding for specified length of time, this is like going for a bike ride with out the dangers of road riding and the weather. Warm up riding you can use an exercise bike for warming up the legs before a leg workout. Also exercise bike classes, these classes are taken by an instructor, who will put you through various levels of pace, quite like a circuit training exercise with a bike.

Swimming also has less impact on the joints than say, running.

If you wish to take your swim a little further try picking up the pace of your swim, you can work up to a great aerobic exercise and give your body an excellent workout.

Start off by swimming 1-2 lengths at a time resting between sets if necessary, after you have swam ten lengths call it a day. A good start point for cardio is always a run.

This cardio workout will work for a person of medium fitness, however adjust the times and pace according to your fitness levels.

1. Run at a light pace for 20 minutes, start off at a walking pace and gradually move to a run, this helps you get warmed up and the blood pumping.

6. The last exercise in this quick cardio workout is the leg raise apparatus.

The number of positions available in health care fields is growing rapidly – including cardiovascular technology jobs. Jobs in cardiovascular technology are those in which people assist physicians and other medical professionals in matters related to the heart and circulatory system. Unlike many positions in the field of medicine however, cardiovascular technology training can be completed in two years.

Those who work at rel=”nofollow” target=”_blank” href=”http://www.edu411.org/”>Cardiovascular Technology jobs assist physicians in the diagnosis and treatment of heart conditions and disorders of the blood and circulation. Jobs in cardiovascular technology fall into one of three major areas: invasive cardiology, echocardiography, and vascular technology.

One of the more interesting cardiovascular jobs is that of a cardiovascular technician. Students who undergo cardiovascular technology training in this particular field learn to administer electrocardiograms (EKGs) and stress tests as well as Holter monitors.

At cardiovascular technology schools, students also learn how to prepare patients for cardiac catheterization and balloon angioplasty. In cardiovascular careers, trained medical professionals monitor blood pressure and heart rate, using EKG equipment in the course of examinations as well as during major surgery.

Another interesting choice among the many cardiovascular technology jobs is that of diagnostic medical sonographer. These workers use ultrasound technology in order to conduct noninvasive examinations of the heart. The instrument scans the patient’s heart with sound waves, providing a picture of conditions inside the heart. As a sonographer, you would need to be able to explain the procedure to the patient, program the equipment and record results.

Cardiovascular technology education may take place online as well as at a traditional brick and mortar school. By preparing for a cardiovascular career over the Internet, you’ll be able to fit most of the coursework around your own schedule – and many courses can be taken at your own pace. Later, when you come to a point in your cardiovascular training that requires actual hands-on clinical experience, the online school can arrange this at a local hospital or other medical treatment facility.

Because the American population is growing older in general and because heart conditions are more common in older people, the job outlook for cardiovascular technology careers is promising. Cardiovascular technology jobs pay between $28,000 and $50,000 per year, depending on experience, location and job settings. About 75% of these jobs are in hospitals; the remainder are in the offices of physicians and other medical facilities. Cardiovascular training programs are offered online through many major accredited universities and colleges across the U.S. and Canada.

Watch the video related to cardiovascular technology

A brief introduction to the Invasive Cardiovascular Technology program at BryanLGH College of Health Sciences, in Lincoln Nebraska

Help answer the question about cardiovascular technology

About Author

Susan Slobac returned to school for Cardiovascular Technology training, upon completion she was was able to enter the field and start her Cardiovascular Technology career. Susan enjoys her job in Cardiovascular Technology and shares her insights into what Cardiovascular Technology schools require and what you can expect from Cardiovascular Technology jobs.

Cardiovascular Technicians assist doctors in patient diagnosis and treatment in a cardiology setting. Some of the functions they perform include ultrasound procedures, monitoring of patients’ heart rates, cardiovascular procedures, review of patient files, explanations of test procedures to the patient, and operation and care of testing equipment. Cardiovascular technologists may specialize in any of three areas of practice: invasive cardiology, echocardiography, or vascular technology. Specialists in invasive cardiology assist doctors with invasive cardiac procedures such as heart catheterizations and angioplasty. Specialists in echocardiography render assistance with non-invasive procedures which do not require the insertion of probes or other instruments into the patient’s body. Some common examples are ultrasound or echocardiograms, electrocardiograms (EKGs), and stress tests. Specialists in vascular technology assist physicians in the diagnosis of disorders affecting circulation and blood flow.

Education, Certification, Licensing

Although some cardiovascular techs (most notably those who focus on administering EKGs) tend to be trained on the job, most receive training in 1- to 4-year programs. Two-year programs offered by junior or community colleges are most popular, although four-year programs are increasingly available. Those who specialize in ultrasound and vascular study will need at least a 2-year program. Those specializing in invasive cardiology procedures will need the 2-4 year program, since this specialty entails the highest degree of complexity. Cardiovascular techs who undergo on-the-job training usually take about 8 to 16 weeks to complete their training. Most employers prefer to train people with at least a minimal degree of experience in a medical setting or who are already in the health care field in some capacity. Some states require cardiovascular techs to be licensed. Those that do mandate licensure usually require some combination of education, experience, and/or certification for earning a license. Information on a particular state’s requirements can be obtained by contacting the state’s medical board. The two principal organizations which offer certifications in this field are the American Registry of Diagnostic Medical Sonographers (ARDMS) and Cardiovascular Credentialing International (CCI). Certification is always beneficial because many employers prefer to hire certified cardiovascular techs even in those states that do not require certification for licensure.

Watch the video related to cardiovascular technology

As a cardiovascular technician, your job is to monitor the heart, collect the appropriate data, help doctors diagnose problems, and prescribe optimal treatments. The US Department of Labor admits that some technicians are trained on the job, but it is quick to point out that the majority of them attend 2-4 year programs in vascular or cardiac medicine. Obviously, formal education in this field will make you better qualified in the long run.

Help answer the question about cardiovascular technology

About Author

This article on baking schools and jobs has been provided courtesy of City Town Info.

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease–sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes–the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes among adults across the world. To compound the global diabetes epidemic, health professionals are witnessing an alarming increase in inflammatory diseases resulting from adult onset (i.e., Type 2) diabetes. This phenomenon is referred to as “metabolic syndrome” where a confluence of inflammatory conditions occur along with the diabetes. As a result, growing evidence appears to show that metabolic syndrome makes the diabetic patient susceptible to degenerative health conditions such as cardiovascular disease, stroke and, now believed, Alzheimer’s disease. As the diabetes epidemic escalates, a new sense of urgency has taken hold. Proactive strategies for prevention of the disease are being put in place by international health organizations such as the World Health Organization (WHO), as well as by the health departments of industrialized and developing countries, and even at the local level where food ingredients regulations are being passed. This  report charts the changing landscape of the global diabetic population and explores the added health concerns resulting from the metabolic syndrome phenomenon and one of its major risk factors: cardiovascular disease (CVD). Furthermore, this study evaluates widely-accepted therapeutic approaches to diabetes that are currently in use, while providing an in-depth analysis of emerging technologies that will be used to treat diabetes and other inflammatory diseases in the future. 
  Table of Contents :

1. Overview 8
1.1 Statement of Report 8
1.2 About this Report 8
1.3 Scope of the Report 9
1.4 Methodology 9
1.5 Executive Summary 11

2. Introduction 17
2.1 Demographics of Diabetes 17
2.1.1 Worldwide Diabetes 17
2.1.2 U.S. Diabetes 18
2.2 Economics of Diabetes 22

3. Understanding the Metabolic Conditions Underlying and Associated with Diabetes 28
3.1 Pre-Diabetes Syndrome 29
3.2 Metabolic Syndrome 29
3.3 Diabetes and Inflammation 32
3.4 Progression of Diabetes 32
3.5 Complications and Co-Morbidities in Type 2 Diabetes 33
3.6 Hypoglycemia and Treatment 38
3.7 Risk Factors and Diabetes 39
3.8 Cardiovascular Disease (CVD) Facts 40

4. Pharmaceutical Industry and the Anti-Diabetes Market 51
4.1 The Worldwide Pharmaceutical Industry 51
4.2 Total Diabetes Drug Market Size and Growth 58
4.2.1 Sales of Anti-Diabetic Drugs Continue to Rise 61
4.3 Epidemiology/Cost of Treatment 62
4.4 Diabetic Medications Overview 63
4.4.1 Recent Trends in Diabetic Drug Usage 63
4.4.2 Market Influence Factors 67

5. Non-Insulin Anti-Diabetes Products 69
5.1 Anti-Diabetic Drug Therapy Overview 69
5.1.1 Sulfonylureas 72
5.1.2 Meglitinides 73
5.1.3 Biguanides 73
5.1.4 Thiazolidinediones (TZDs) 74
5.1.5 a-Glucosidase Inhibitors 77
5.1.6 Incretin Mimetics/Glucagon-like Peptide (GLP-1) Analog 77
5.1.7 Amylin Analog 79
5.1.8 DPP-IV Inhibitors 79
5.1.9 Other Classes 81
5.1.10 Combination Therapy 81
5.2 Drivers and Trends 82
5.2.1 Market Share of Anti-Diabetic Drugs 82
5.2.2 Forecasts for Anti-Diabetic Drugs 82
5.2.3 Sales Forecast for the Global Diabetes Market 83
5.3 The Future 84
5.3.1 Practice Patterns 84
5.3.2 New Products in Pipeline 85
5.4 Anti-Diabetic Drug Patent Expiry 91
5.5 Regulatory Issues 91

6. Insulin 92
6.1 Insulin Markets 92
6.1.1 Major Players and Market Share 93
6.2 Insulin and Analogs 95
6.2.1 Rapid-Acting Insulin 95
6.2.2 Intermediate-Acting Insulin 97
6.2.3 Long-Acting Insulin/Ultra Long-Acting Insulin 97
6.2.4 Insulin Mixtures 99
6.3 Insulin Analogs 100
6.4 Non-Insulins in Development 100
6.5 Pipeline Insulin 101
6.6 Non-Invasive Insulin Delivery 101
6.6.1 Inhaled Insulin 101
6.6.1.1 Inhaled Insulin Overview 102
6.6.2 Oral Insulin 104
6.6.3 Transdermal Insulin 106
6.6.4 Oral Spray Insulin 108
6.7 Barriers for Non-Injected Insulin 109
6.8 Patient Potential for Non-Injected Insulin 109
6.9 Insulin Delivery Devices 109
6.9.1 Lancets and Lancing Devices 110
6.9.2 Insulin Pens 113
6.9.3 Injections Aids 117
6.9.3.1 Automatic Injectors 117
6.9.3.2 Syringe Magnifiers 118
6.9.3.3 Insulin Infusers 118
6.9.4 Insulin Jet Injectors 118
6.9.5 Insulin Pumps 119
6.9.5.1 External Insulin Pumps 119
6.9.5.2 Implantable Insulin Pumps 122
6.9.5.3 Insulin Pump Market Share 123
6.9.5.4 Drivers of Demand for Pumps 128
6.10 Market Forecasts for Insulin Administration Technologies 129

7. Emerging Anti-Diabetes Products 130
7.1 Projections for the Anti-Diabetes Drug Market 130
7.2 Artificial Pancreas 134
7.3 Insulin-Producing Cells 135
7.3.1 Cell Therapy Companies for Diabetes 135
7.4 Transplantation Procedures 137
7.4.1 Pancreatic Transplantation 138
7.4.1.1 Pancreatic Organ Transplantation 138
7.4.1.2 Allo-Islet Transplantation 138
7.4.1.3 Transplantation of Encapsulated Pancreatic Cells 139
7.4.1.4 Implantation of Genetically Engineered-Cells or Embryonic Stem Cells 139
7.4.2 Current Status 140
7.5 Gastric Bypass Surgery to Treat Type 2 Diabetes 140
7.6 Immune Modulators 141
7.7 Anti-Obesity Drug Xenical to Prevent or Delay Development of Type 2 Diabetes 141
7.8 Other Anti-Diabetic Therapy Drug Candidates 141
7.8.1 Lipid Abnormalities 142
7.8.2 High Blood Pressure 143
7.8.3 Anticoagulants 144
7.9 Drugs Used “Off-Label” 145
7.9.1 Niacin Derivatives 145
7.9.2 Benfluorex 145
7.9.3 D-Chiro-Inositol 145
7.9.4 Warfarin Sodium 145
7.10 Pipeline Diabetic Drug Candidates 146
7.11 Drug Research Overview 149
7.12 Future Anti-Diabetic Drugs in Late-Stage Development 151

8. Diagnosing Diabetes Using In Vitro Laboratory Tests 154
8.1 New Diagnostic Guidelines 154
8.2 Diabetes Tests 155
8.2.1 Fasting Plasma Glucose (FPG) Test 155
8.2.2 Glucose Tolerance Test 155
8.2.3 Test for Glycosylated Hemoglobin 156
8.2.4 Fructosamine 157
8.3 Glucose Monitoring 157
8.3.1 Overview of Market Segment 160
8.3.2 Competitive Strategies 160
8.3.3 Analyses of the Current Market Conditions, Competition and Product Mix 162
8.3.3.1 First-Generation Monitors 162
8.3.3.2 Second-Generation Monitors 162
8.3.3.3 Third-Generation SMBG Technologies 164
8.3.3.4 Product Overview 165
8.3.3.4.1 LifeScan 165
8.3.3.4.2 Roche Diagnostics 168
8.3.3.4.3 Bayer Diagnostics 169
8.3.3.4.4 Abbott Diagnostics 172
8.3.3.4.5 Other Players 174
8.3.4 What Are the Advantages of Using a Continuous Glucose-Monitoring Device? 177
8.3.5 Other Monitoring Device Advancements 178
8.3.6 Future of Non-Invasive Glucose Technology 179

9. Market Trends, Challenges and Strategic Options 182
9.1 Overview 182
9.2 Diabetes Drug Market Trends 182
9.2.1 Overview 182
9.2.2 Emergence of Therapeutics with Improved Administration Characteristics 182
9.2.3 Increasing Prevalence of Obesity 183
9.3 Diabetes Mellitus Market Challenges 185
9.3.1 Overview 185
9.3.2 Diabetic Pain Therapeutics 185
9.3.3 Market Prospects of Inhalable Drugs and Their Ability to Establish Safety Levels 186
9.3.4 Changing Consumer Preference Drives Product Development in Invasive Technology Segment 186
9.3.5 Non-Invasive Technology for Revenue Potential 186
9.3.6 Developing Countries Emerging as Key Markets for Diabetes Monitoring Devices 187
9.3.7 Consumer-Driven Marketing Campaigns—Essential, though Expensive 189
9.3.8 Escalating Expenditure for R&D and Marketing Triggers Consolidation 189
9.3.9 Market Size Predictions 191
9.3.10 Major Competitors 191
9.4 Strategic Options 192
9.4.1 Overview 192
9.4.2 Combined Self-Testing Glucose Monitor with Insulin Delivery 193
9.4.3 Diabetes Drugs in Pipeline 194
9.5 FDA Therapeutic Targets 196
9.5.1 FDA Targets Cardiotoxicity 197
9.5.2 Avandia FDA Warning 197
9.6 Outlook to Anti-Diabetes Drugs 197
9.7 Outlook for Cardiovascular Drugs 201

10. Company Profiles 203
10.1 A. Menarini 203
10.2 Abbott Laboratories 203
10.3 Amgen 204
10.4 AstraZeneca 205
10.5 Bayer 206
10.6 BodyMedia 208
10.7 Cybermedical 208
10.8 Debiotech 208
10.9 DexCom 209
10.10 Echo Therapeutics 210
10.11 Elixir Pharmaceuticals 211
10.12 Eksigent 211
10.13 Flamel Technologies 211
10.14 GlaxoSmithKline 212
10.15 GlucoLight 212
10.16 Insulet 212
10.17 iSense Corporation 213
10.18 Isis Pharmaceuticals, Inc. 213
10.19 Johnson & Johnson 214
10.20 KYORIN 215
10.21 M-Biotech 215
10.22 Medtronic 215
10.23 Merck & Co. 217
10.24 Merck KGaA 218
10.25 MicroIslet 218
10.26 Mitsubishi Tanabe Pharma Corporation 219
10.27 Nipro Diabetes Systems 219
10.28 Novartis 219
10.29 Novo Nordisk 220
10.30 Novocell 221
10.31 ONO Pharmaceutical 221
10.32 Orexigen Therapeutics 222
10.33 Pfizer 223
10.34 ReNeuron 223
10.35 Roche Diagnostics 224
10.36 Sanofi-Aventis 225
10.37 Sensors for Medicine and Science 226
10.38 Siemens 227
10.39 Smiths Medical 227
10.40 Servier 228
10.41 SOOIL Development 228
10.42 Takeda 228
10.43 TheraFuse 229
10.44 Teco Diagnostics 229
10.45 Transition Therapeutics 229
10.46 U.S. Diagnostics 229
10.47 VeraLight 230
10.48 Vivus 230
10.49 Ypsomed Holding 231

Appendix 1: Contact Information for Companies Profiled 232
Appendix 2: Prescribing Patterns for Anti-Hyperglycemic Drugs 238
Appendix 3: Detailed List of Insulins Available 239
Appendix 4: The History of Insulin 240
Appendix 5: Diabetes and Obesity Drugs in Development 245
Appendix 6: Pharmaceutical Sampling Practices 253

http://www.aarkstore.com/reports/Diabetes-Metabolic-Syndrome-and-Cardiovascular-Disease-1310.html

Watch the video related to cardiovascular technology

Stacey’s Graduation – Valedictorian 2009

Help answer the question about cardiovascular technology

About Author

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers. Our customers include more than 700 leading financial institutions, professional service firms, consulting, law and accounting firms and other corporations throughout the world.